0001437749-16-026178.txt : 20160226
0001437749-16-026178.hdr.sgml : 20160226
20160226164347
ACCESSION NUMBER: 0001437749-16-026178
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160226
DATE AS OF CHANGE: 20160226
EFFECTIVENESS DATE: 20160226
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001389545
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680454536
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-258212
FILM NUMBER: 161462646
BUSINESS ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 899-8800
MAIL ADDRESS:
STREET 1: 5980 HORTON STREET
STREET 2: SUITE 550
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
D
1
primary_doc.xml
X0707
D
LIVE
0001389545
NovaBay Pharmaceuticals, Inc.
5980 HORTON STREET
SUITE 550
EMERYVILLE
CA
CALIFORNIA
94608
(510) 899-8800
DELAWARE
NovaCal Pharmaceuticals, Inc.
None
Corporation
true
Mark
M.
Sieczkarek
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Executive Officer
Director
Thomas
J.
Paulson
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Executive Officer
Justin
M.
Hall
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Executive Officer
Roy
J.
Wu
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Executive Officer
Paul
E.
Freiman
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Xinzhou (Paul)
Li
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Gail
J.
Maderis
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
T.
Alex
McPherson
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Massimo
Radaelli
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Xiaoyan
Liu
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Mijia
Wu
5980 Horton Street, Suite 550
Emeryville
CA
CALIFORNIA
94608
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-02-16
false
true
false
0
China Kington Asset Management Co. Ltd.
None
None
None
Suite 6C, Bldg 3, You You Century Plz
No.428 Yang Gao, S. Rd, Pu Dong New Dist
Shanghai
F4
CHINA
200127
true
2830804
2830804
0
$239,489.17 of securities were offered and sold within the United States, and $2,591,314.80 of securities were offered and sold
in non-U.S. jurisdictions.
false
3
155479
0
No commissions were paid on sales to U.S. citizens or persons or entities domiciled within the United States.
0
false
NovaBay Pharmaceuticals, Inc.
/s/ Thomas J. Paulson
Thomas J. Paulson
Chief Financial Officer
2016-02-26